WallStSmart

MKS Instruments Inc (MKSI)vsMesa Laboratories Inc (MLAB)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

MKS Instruments Inc generates 1535% more annual revenue ($4.07B vs $249.13M). MKSI leads profitability with a 8.0% profit margin vs 2.7%. MKSI trades at a lower P/E of 74.6x. MKSI earns a higher WallStSmart Score of 61/100 (C+).

MKSI

Buy

61

out of 100

Grade: C+

Growth: 7.3Profit: 6.5Value: 3.3Quality: 5.0
Piotroski: 4/9Altman Z: 1.24

MLAB

Avoid

30

out of 100

Grade: F

Growth: 3.3Profit: 4.0Value: 5.7Quality: 5.5
Piotroski: 5/9Altman Z: 0.70
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

MKSISignificantly Overvalued (-75.4%)

Margin of Safety

-75.4%

Fair Value

$147.68

Current Price

$301.65

$153.97 premium

UndervaluedFair: $147.68Overvalued
MLABUndervalued (+64.0%)

Margin of Safety

+64.0%

Fair Value

$253.18

Current Price

$104.38

$148.80 discount

UndervaluedFair: $253.18Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

MKSI2 strengths · Avg: 9.0/10
EPS GrowthGrowth
53.2%10/10

Earnings expanding 53.2% YoY

Revenue GrowthGrowth
15.2%8/10

15.2% revenue growth

MLAB0 strengths · Avg: 0/10

No standout strengths identified

Areas to Watch

MKSI2 concerns · Avg: 2.0/10
P/E RatioValuation
74.6x2/10

Premium valuation, high expectations priced in

Altman Z-ScoreHealth
1.242/10

Distress zone — elevated risk

MLAB4 concerns · Avg: 3.3/10
Revenue GrowthGrowth
2.6%4/10

2.6% revenue growth

Market CapQuality
$573.99M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
3.6%3/10

ROE of 3.6% — below average capital efficiency

Profit MarginProfitability
2.7%3/10

2.7% margin — thin

Comparative Analysis Report

WallStSmart Research

Bull Case : MKSI

The strongest argument for MKSI centers on EPS Growth, Revenue Growth. Revenue growth of 15.2% demonstrates continued momentum. PEG of 1.32 suggests the stock is reasonably priced for its growth.

Bull Case : MLAB

MLAB has a balanced fundamental profile.

Bear Case : MKSI

The primary concerns for MKSI are P/E Ratio, Altman Z-Score. A P/E of 74.6x leaves little room for execution misses.

Bear Case : MLAB

The primary concerns for MLAB are Revenue Growth, Market Cap, Return on Equity. A P/E of 85.9x leaves little room for execution misses. Thin 2.7% margins leave little buffer for downturns.

Key Dynamics to Monitor

MKSI profiles as a growth stock while MLAB is a value play — different risk/reward profiles.

MKSI carries more volatility with a beta of 2.00 — expect wider price swings.

MKSI is growing revenue faster at 15.2% — sustainability is the question.

MKSI generates stronger free cash flow (28M), providing more financial flexibility.

Bottom Line

MKSI scores higher overall (61/100 vs 30/100) and 15.2% revenue growth. MLAB offers better value entry with a 64.0% margin of safety. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

MKS Instruments Inc

TECHNOLOGY · SCIENTIFIC & TECHNICAL INSTRUMENTS · USA

MKS Instruments, Inc. provides instruments, systems, subsystems, and process control solutions that measure, monitor, deliver, analyze, power, and control critical parameters of manufacturing processes globally. The company is headquartered in Andover, Massachusetts.

Visit Website →

Mesa Laboratories Inc

TECHNOLOGY · SCIENTIFIC & TECHNICAL INSTRUMENTS · USA

Mesa Laboratories, Inc. designs, manufactures, and markets quality control instruments and disposable products in the United States, Europe, Asia, North America, and internationally. The company is headquartered in Lakewood, Colorado.

Want to dig deeper into these stocks?